Blog
Sep 12

Dr Jinjie Hu appointed by LAM as CRO – Biospace

Laboratory for Advanced Medicine (LAM) – Following the launch of cancer-testing platform IvyGene, Irvine, Calif.-based LAM named Jinjie Hu as its new chief regulatory officer. Hu has more than a decade of experience working directly with the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research. Hu served as president and principal consultant at Axteria BioMed Consulting, Inc. and also served as a senior consultant for Biologics Consulting Group. Additionally, Hu served as a World Health Organization adviser for its diagnostic prequalification program.

Leave a reply

Your email address will not be published. Required fields are marked *